Fecal Microbiota Transplantation plus Anti-PD-1 Is Safe in a First-line Setting
- PMID: 37449731
- DOI: 10.1158/2159-8290.CD-RW2023-109
Fecal Microbiota Transplantation plus Anti-PD-1 Is Safe in a First-line Setting
Abstract
Fecal microbiota transplantation combined with anti-PD-1 is safe in melanoma in the first-line setting.
©2023 American Association for Cancer Research.
Comment on
-
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.Nat Med. 2023 Aug;29(8):2121-2132. doi: 10.1038/s41591-023-02453-x. Epub 2023 Jul 6. Nat Med. 2023. PMID: 37414899 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
